Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Tumor-Selective Altered Glycosylation and Functional Attenuation of CD73 in Human Hepatocellular Carcinoma.

Alcedo KP, Guerrero A, Basrur V, Fu D, Richardson ML, McLane JS, Tsou CC, Nesvizhskii AI, Welling TH, Lebrilla CB, Otey CA, Kim HJ, Omary MB, Snider NT.

Hepatol Commun. 2019 Aug 9;3(10):1400-1414. doi: 10.1002/hep4.1410. eCollection 2019 Oct.

2.

The Role of Palladin in Podocytes.

Artelt N, Ludwig TA, Rogge H, Kavvadas P, Siegerist F, Blumenthal A, van den Brandt J, Otey CA, Bang ML, Amann K, Chadjichristos CE, Chatziantoniou C, Endlich K, Endlich N.

J Am Soc Nephrol. 2018 Jun;29(6):1662-1678. doi: 10.1681/ASN.2017091039. Epub 2018 May 2.

3.

Suppression of TGFβ-mediated conversion of endothelial cells and fibroblasts into cancer associated (myo)fibroblasts via HDAC inhibition.

Kim DJ, Dunleavey JM, Xiao L, Ollila DW, Troester MA, Otey CA, Li W, Barker TH, Dudley AC.

Br J Cancer. 2018 May;118(10):1359-1368. doi: 10.1038/s41416-018-0072-3. Epub 2018 Apr 26.

4.

Palladin Compensates for the Arp2/3 Complex and Supports Actin Structures during Listeria Infections.

Dhanda AS, Vogl AW, Albraiki SE, Otey CA, Beck MR, Guttman JA.

MBio. 2018 Apr 10;9(2). pii: e02259-17. doi: 10.1128/mBio.02259-17.

5.

The actin crosslinking protein palladin modulates force generation and mechanosensitivity of tumor associated fibroblasts.

Azatov M, Goicoechea SM, Otey CA, Upadhyaya A.

Sci Rep. 2016 Jun 29;6:28805. doi: 10.1038/srep28805.

6.

Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression.

Cannon AR, Owen MK, Guerrero MS, Kerber ML, Goicoechea SM, Hemstreet KC, Klazynski B, Hollyfield J, Chang EH, Hwang RF, Otey CA, Kim HJ.

Cytoskeleton (Hoboken). 2015 Aug;72(8):402-11. doi: 10.1002/cm.21239. Epub 2015 Sep 3.

PMID:
26333695
7.

Palladin is upregulated in kidney disease and contributes to epithelial cell migration after injury.

Chang EH, Gasim AH, Kerber ML, Patel JB, Glaubiger SA, Falk RJ, Jennette JC, Otey CA.

Sci Rep. 2015 Jan 9;5:7695. doi: 10.1038/srep07695.

8.

Actin dynamics regulate subcellular localization of the F-actin-binding protein PALLD in mouse Sertoli cells.

Niedenberger BA, Chappell VA, Otey CA, Geyer CB.

Reproduction. 2014 Oct;148(4):333-41. doi: 10.1530/REP-14-0147. Epub 2014 Jul 2.

PMID:
24989903
9.

Structure and function of palladin's actin binding domain.

Beck MR, Dixon RD, Goicoechea SM, Murphy GS, Brungardt JG, Beam MT, Srinath P, Patel J, Mohiuddin J, Otey CA, Campbell SL.

J Mol Biol. 2013 Sep 23;425(18):3325-37. doi: 10.1016/j.jmb.2013.06.016. Epub 2013 Jun 25.

10.

Palladin promotes invasion of pancreatic cancer cells by enhancing invadopodia formation in cancer-associated fibroblasts.

Goicoechea SM, García-Mata R, Staub J, Valdivia A, Sharek L, McCulloch CG, Hwang RF, Urrutia R, Yeh JJ, Kim HJ, Otey CA.

Oncogene. 2014 Mar 6;33(10):1265-73. doi: 10.1038/onc.2013.68. Epub 2013 Mar 25.

11.

Morphology and viscoelasticity of actin networks formed with the mutually interacting crosslinkers: palladin and alpha-actinin.

Grooman B, Fujiwara I, Otey C, Upadhyaya A.

PLoS One. 2012;7(8):e42773. doi: 10.1371/journal.pone.0042773. Epub 2012 Aug 16.

12.

Near-field radiative cooling of nanostructures.

Guha B, Otey C, Poitras CB, Fan S, Lipson M.

Nano Lett. 2012 Sep 12;12(9):4546-50. doi: 10.1021/nl301708e. Epub 2012 Aug 30.

PMID:
22891815
13.

Structural characterization of the interactions between palladin and α-actinin.

Beck MR, Otey CA, Campbell SL.

J Mol Biol. 2011 Oct 28;413(3):712-25. doi: 10.1016/j.jmb.2011.08.059. Epub 2011 Sep 8.

14.

Comparison of the incidence of pancreatic abnormalities between high risk and control patients: prospective pilot study with 3 Tesla MR imaging.

Shin SS, Armao DM, Burke LM, Kim HJ, Skrzynia C, Otey CA, Semelka RC.

J Magn Reson Imaging. 2011 May;33(5):1080-5. doi: 10.1002/jmri.22551.

PMID:
21509864
15.

The actin associated protein palladin is important for the early smooth muscle cell differentiation.

Jin L, Gan Q, Zieba BJ, Goicoechea SM, Owens GK, Otey CA, Somlyo AV.

PLoS One. 2010 Sep 22;5(9):e12823. doi: 10.1371/journal.pone.0012823.

16.

Thermal rectification through vacuum.

Otey CR, Lau WT, Fan S.

Phys Rev Lett. 2010 Apr 16;104(15):154301. Epub 2010 Apr 13.

PMID:
20481993
17.

Isoform-specific upregulation of palladin in human and murine pancreas tumors.

Goicoechea SM, Bednarski B, Stack C, Cowan DW, Volmar K, Thorne L, Cukierman E, Rustgi AK, Brentnall T, Hwang RF, McCulloch CA, Yeh JJ, Bentrem DJ, Hochwald SN, Hingorani SR, Kim HJ, Otey CA.

PLoS One. 2010 Apr 26;5(4):e10347. doi: 10.1371/journal.pone.0010347.

18.

Directed evolution of a magnetic resonance imaging contrast agent for noninvasive imaging of dopamine.

Shapiro MG, Westmeyer GG, Romero PA, Szablowski JO, Küster B, Shah A, Otey CR, Langer R, Arnold FH, Jasanoff A.

Nat Biotechnol. 2010 Mar;28(3):264-70. doi: 10.1038/nbt.1609. Epub 2010 Feb 28.

19.

Cytoplasmic Ig-domain proteins: cytoskeletal regulators with a role in human disease.

Otey CA, Dixon R, Stack C, Goicoechea SM.

Cell Motil Cytoskeleton. 2009 Aug;66(8):618-34. doi: 10.1002/cm.20385. Review.

20.

Palladin is a dynamic actin-associated protein in podocytes.

Endlich N, Schordan E, Cohen CD, Kretzler M, Lewko B, Welsch T, Kriz W, Otey CA, Endlich K; European Renal cDNA Bank Consortium.

Kidney Int. 2009 Jan;75(2):214-26. doi: 10.1038/ki.2008.486. Epub 2008 Oct 1.

21.

Roles of the small GTPases RhoA and Rac1 in cell behavior.

Otey C, Goicoechea S, Garcia-Mata R.

F1000 Biol Rep. 2009 Jan 21;1:4. doi: 10.3410/B1-4.

22.

Characterization of cortactin as an in vivo protein kinase D substrate: interdependence of sites and potentiation by Src.

De Kimpe L, Janssens K, Derua R, Armacki M, Goicoechea S, Otey C, Waelkens E, Vandoninck S, Vandenheede JR, Seufferlein T, Van Lint J.

Cell Signal. 2009 Feb;21(2):253-63. doi: 10.1016/j.cellsig.2008.10.015. Epub 2008 Oct 29.

PMID:
19038333
23.

Palladin contributes to invasive motility in human breast cancer cells.

Goicoechea SM, Bednarski B, García-Mata R, Prentice-Dunn H, Kim HJ, Otey CA.

Oncogene. 2009 Jan 29;28(4):587-98. doi: 10.1038/onc.2008.408. Epub 2008 Nov 3.

24.

The role of palladin in actin organization and cell motility.

Goicoechea SM, Arneman D, Otey CA.

Eur J Cell Biol. 2008 Sep;87(8-9):517-25. doi: 10.1016/j.ejcb.2008.01.010. Epub 2008 Mar 14. Review.

25.

Palladin is an actin cross-linking protein that uses immunoglobulin-like domains to bind filamentous actin.

Dixon RD, Arneman DK, Rachlin AS, Sundaresan NR, Costello MJ, Campbell SL, Otey CA.

J Biol Chem. 2008 Mar 7;283(10):6222-31. doi: 10.1074/jbc.M707694200. Epub 2008 Jan 7. Erratum in: J Biol Chem. 2008 Oct 3;283(40):27344.

26.

Movement of stress fibers away from focal adhesions identifies focal adhesions as sites of stress fiber assembly in stationary cells.

Endlich N, Otey CA, Kriz W, Endlich K.

Cell Motil Cytoskeleton. 2007 Dec;64(12):966-76.

PMID:
17868136
27.

Human adipose-derived adult stem cells upregulate palladin during osteogenesis and in response to cyclic tensile strain.

Wall ME, Rachlin A, Otey CA, Loboa EG.

Am J Physiol Cell Physiol. 2007 Nov;293(5):C1532-8. Epub 2007 Aug 8.

28.

Palladin interacts with SH3 domains of SPIN90 and Src and is required for Src-induced cytoskeletal remodeling.

Rönty M, Taivainen A, Heiska L, Otey C, Ehler E, Song WK, Carpen O.

Exp Cell Res. 2007 Jul 15;313(12):2575-85. Epub 2007 May 8.

29.

Diversification of catalytic function in a synthetic family of chimeric cytochrome p450s.

Landwehr M, Carbone M, Otey CR, Li Y, Arnold FH.

Chem Biol. 2007 Mar;14(3):269-78.

30.
31.

Palladin mutation causes familial pancreatic cancer and suggests a new cancer mechanism.

Pogue-Geile KL, Chen R, Bronner MP, Crnogorac-Jurcevic T, Moyes KW, Dowen S, Otey CA, Crispin DA, George RD, Whitcomb DC, Brentnall TA.

PLoS Med. 2006 Dec;3(12):e516.

32.

Connexin 43 is localized with actin in tenocytes.

Wall ME, Otey C, Qi J, Banes AJ.

Cell Motil Cytoskeleton. 2007 Feb;64(2):121-30.

PMID:
17183550
33.

Palladin binds to Eps8 and enhances the formation of dorsal ruffles and podosomes in vascular smooth muscle cells.

Goicoechea S, Arneman D, Disanza A, Garcia-Mata R, Scita G, Otey CA.

J Cell Sci. 2006 Aug 15;119(Pt 16):3316-24. Epub 2006 Jul 25.

34.

Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation.

Rönty MJ, Leivonen SK, Hinz B, Rachlin A, Otey CA, Kähäri VM, Carpén OM.

J Invest Dermatol. 2006 Nov;126(11):2387-96. Epub 2006 Jun 22.

35.

Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450 BM-3.

Landwehr M, Hochrein L, Otey CR, Kasrayan A, Bäckvall JE, Arnold FH.

J Am Chem Soc. 2006 May 10;128(18):6058-9.

36.

Structure-guided recombination creates an artificial family of cytochromes P450.

Otey CR, Landwehr M, Endelman JB, Hiraga K, Bloom JD, Arnold FH.

PLoS Biol. 2006 May;4(5):e112. Epub 2006 Apr 11.

37.

Protein stability promotes evolvability.

Bloom JD, Labthavikul ST, Otey CR, Arnold FH.

Proc Natl Acad Sci U S A. 2006 Apr 11;103(15):5869-74. Epub 2006 Mar 31.

38.
39.

The proline-rich protein palladin is a binding partner for profilin.

Boukhelifa M, Moza M, Johansson T, Rachlin A, Parast M, Huttelmaier S, Roy P, Jockusch BM, Carpen O, Karlsson R, Otey CA.

FEBS J. 2006 Jan;273(1):26-33.

40.

Four and half lim protein 2 (FHL2) stimulates osteoblast differentiation.

Lai CF, Bai S, Uthgenannt BA, Halstead LR, McLoughlin P, Schafer BW, Chu PH, Chen J, Otey CA, Cao X, Cheng SL.

J Bone Miner Res. 2006 Jan;21(1):17-28. Epub 2005 Oct 3.

41.

Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450.

Otey CR, Bandara G, Lalonde J, Takahashi K, Arnold FH.

Biotechnol Bioeng. 2006 Feb 20;93(3):494-9.

PMID:
16224788
42.

The palladin/myotilin/myopalladin family of actin-associated scaffolds.

Otey CA, Rachlin A, Moza M, Arneman D, Carpen O.

Int Rev Cytol. 2005;246:31-58. Review.

PMID:
16164966
43.

Evolving strategies for enzyme engineering.

Bloom JD, Meyer MM, Meinhold P, Otey CR, MacMillan D, Arnold FH.

Curr Opin Struct Biol. 2005 Aug;15(4):447-52. Review.

PMID:
16006119
44.

Molecular analysis of the interaction between palladin and alpha-actinin.

Rönty M, Taivainen A, Moza M, Otey CA, Carpén O.

FEBS Lett. 2004 May 21;566(1-3):30-4.

45.

Simultaneous stretching and contraction of stress fibers in vivo.

Peterson LJ, Rajfur Z, Maddox AS, Freel CD, Chen Y, Edlund M, Otey C, Burridge K.

Mol Biol Cell. 2004 Jul;15(7):3497-508. Epub 2004 May 7.

46.

Functional evolution and structural conservation in chimeric cytochromes p450: calibrating a structure-guided approach.

Otey CR, Silberg JJ, Voigt CA, Endelman JB, Bandara G, Arnold FH.

Chem Biol. 2004 Mar;11(3):309-18.

47.

Alpha-actinin revisited: a fresh look at an old player.

Otey CA, Carpen O.

Cell Motil Cytoskeleton. 2004 Jun;58(2):104-11. Review. No abstract available.

PMID:
15083532
48.

Biomedical research publication system.

Wang YL, Burridge K, Dembo M, Gabbiani G, Hanks SK, Hosoya H, Janmey P, Karlsson R, Lindberg U, Mabuchi I, Otey C, Rottner K, Small JV, Wang CL, Zigmond S.

Science. 2004 Mar 26;303(5666):1974-6. No abstract available.

PMID:
15044785
49.

Palladin is a novel binding partner for Ena/VASP family members.

Boukhelifa M, Parast MM, Bear JE, Gertler FB, Otey CA.

Cell Motil Cytoskeleton. 2004 May;58(1):17-29.

PMID:
14983521
50.

Modulation of corneal fibroblast contractility within fibrillar collagen matrices.

Vishwanath M, Ma L, Otey CA, Jester JV, Petroll WM.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4724-35.

PMID:
14578392

Supplemental Content

Support Center